Asian Phytoceuticals PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	200.17	210.83	292.76	250.38	223.35
Revenue Growth (YoY)	-5.06%	-27.99%	16.93%	12.10%	-9.84%
Cost of Revenue	31.15	40.96	57.25	47.94	46.26
Gross Profit	169.02	169.87	235.52	202.44	177.09
Selling, General & Admin	115.44	120.1	119.72	116.49	106.29
Other Operating Expenses	-2.38	-3.34	-1.09	-2.08	-3.03
Operating Expenses	113.06	116.76	118.63	114.41	103.27
Operating Income	55.96	53.11	116.89	88.03	73.82
Interest Expense	-1.61	-1.59	-0.66	-0.57	-0.86
Interest & Investment Income	6.88	13.05	15.22	12.41	10.31
Earnings From Equity Investments	1.65	1.67	1.26	0.61	-0.28
EBT Excluding Unusual Items	62.88	66.24	132.72	100.48	82.98
Gain (Loss) on Sale of Investments	6.87	1.73	0.47	-0.01	2.51
Pretax Income	69.75	67.98	133.18	100.47	85.49
Income Tax Expense	13.14	12.21	24.45	19.28	16.79
Earnings From Continuing Operations	56.6	55.77	108.74	81.2	68.7
Minority Interest in Earnings	-1.19	-1.06	-1.24	-0.28	-
Net Income	55.41	54.71	107.49	80.92	68.7
Net Income to Common	55.41	54.71	107.49	80.92	68.7
Net Income Growth	1.28%	-49.10%	32.84%	17.78%	-1.82%
Shares Outstanding (Basic)	616	608	601	600	600
Shares Outstanding (Diluted)	616	608	601	600	600
Shares Change (YoY)	1.28%	1.23%	0.11%	-0.03%	-0.02%
EPS (Basic)	0.09	0.09	0.18	0.13	0.11
EPS (Diluted)	0.09	0.09	0.18	0.13	0.11
EPS Growth	-	-49.72%	32.69%	17.82%	-1.80%
Free Cash Flow	51.42	35.36	120.72	99.86	83.22
Free Cash Flow Per Share	0.08	0.06	0.20	0.17	0.14
Dividend Per Share	0.091	0.092	0.180	0.155	0.123
Dividend Growth	-1.09%	-48.89%	16.13%	25.61%	2.83%
Gross Margin	84.44%	80.57%	80.45%	80.85%	79.29%
Operating Margin	27.96%	25.19%	39.93%	35.16%	33.05%
Profit Margin	27.68%	25.95%	36.72%	32.32%	30.76%
Free Cash Flow Margin	25.69%	16.77%	41.24%	39.88%	37.26%
EBITDA	61.12	59.29	123.69	94.84	81.48
EBITDA Margin	30.54%	28.12%	42.25%	37.88%	36.48%
D&A For EBITDA	5.16	6.18	6.8	6.81	7.66
EBIT	55.96	53.11	116.89	88.03	73.82
EBIT Margin	27.96%	25.19%	39.93%	35.16%	33.05%
Effective Tax Rate	18.84%	17.96%	18.36%	19.19%	19.64%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.